SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.